ANAMA — Bahrain has authorized a clinical study to evaluate the use of Enovid nasal spray to treat individuals with COVID-19. The authorization by Bahrain’s National Health Regulatory Authority (NHRA) follows a medical study submitted by the relevant authorities at the Ministry of Health, which indicates their support for a clinical trial to take place in Bahrain. Enovid will be tested on volunteers who have already been diagnosed with COVID-19 and who are suffering from mild symptoms.
Read more here.
The post [SaNOtize in Saudi Gazette] Bahrain authorizes use of nasal spray to treat and prevent COVID-19 appeared first on OurCrowd Blog.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.
